Navigation Links
Schering-Plough to Webcast Special Meeting of Shareholders
Date:8/6/2009

KENILWORTH, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will provide a live Webcast of its Special Shareholders Meeting being held on Friday, August 7, 2009, at 1:30 p.m. (EDT) regarding the proposed merger between Schering-Plough and Merck & Co., Inc. Originating from Boston, the Webcast will be available to all interested parties via the corporate Web site, www.schering-plough.com.

Those wishing to listen live to the Webcast of the Special Meeting should go to the Investor Relations section of the Schering-Plough corporate Web site, www.schering-plough.com, and click on the "Presentations/Webcasts" link. A replay of the Webcast will be available via the Web site later that day.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
2. New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
3. Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
4. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
5. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
6. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
7. Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
8. Schering-Plough Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Largest in N.J., North America
9. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
10. Schering-Plough Reports Financial Results for 2009 First Quarter
11. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... MEDsys ... Medicaid programs, Managed Care Organizations and Home Care Agencies, has been awarded CIO ... VinCENT, provides technology solutions to over 1,000 agencies and multiple State Medicaid and ...
(Date:7/27/2017)... ... 27, 2017 , ... GAFFEY Healthcare, a leading provider of ... to Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice ... executive officer (CEO). , Elrene has been with company since Oct 2014 and ...
(Date:7/27/2017)... ... 2017 , ... Healthy eating isn’t always easy. Currently, more than 80 percent of Americans fail ... overeat refined grains and sugar. This trend may help explain why the obesity rate seems ... obese. , As a culture, we seem to have food on the brain more. "We ...
(Date:7/27/2017)... ... July 27, 2017 , ... The Freedom from ... startup companies around 117 breakthrough inventions from 55 institutions, including the National Institutes ... Institute of Biomedical Imaging and Bioengineering), the United States Army, and more than ...
(Date:7/27/2017)... ... ... Cremations recently surpassed traditional burials for the first time in the U.S. ... with over 70% of Americans projected to choose cremation by 2030. , In line ... to celebrate the life of a lost loved one in different ways using their ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... is a revolutionary new product that relieves painful carpal tunnel syndrome ... affects more than 8 million people a year. Women suffer from ... methods of treating CTS are painful surgery, the use of NSAIDs ... ... a clear patch worn on the palm of the hand. It ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology: